Eupraxia Pharmaceuticals Inc.
- Biotech or pharma, therapeutic R&D
Eupraxia Pharmaceuticals Inc. (TSX: EPRX, NASDAQ: EPRX) is a clinical-stage biotechnology company headquartered in Victoria, British Columbia, Canada. Eupraxia is focused on the sustained local delivery of therapeutics through its proprietary Diffusphere™ technology—a highly differentiated drug delivery platform (ultra thin polymer) designed to precisely release medications for up to 12 months. This technology achieves an exceptionally low initial Cmax and eliminates subsequent pharmacokinetic (PK) excursions. Eupraxia’s pipeline targets diseases with significant unmet medical needs, offering the potential for more effective, longer-lasting treatments with improved safety and pharmacokinetic profiles.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}